A hexameric molecule composed of IgG1 and IgG4 has been generated to limit the activation of complement, cytokine production and platelet activation but preserving FcγR blocking and showed its capability to prevent ITP in a murine model [78]. Here, FCGR2A is linked to autoimmune thrombocytopenic purpura.